In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Chris Turck
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Chris Turck

RESEARCHER INFORMATION
First Name:Chris
Last Name:Turck
Title:Prof.
Advanced Degrees:Ph.D.
Affiliation:Max Planck Institute of Psychiatry
Department:Proteomics
Street Address 1:Kraepelinstr. 2
City:Munich
Zip/Postal Code:D-80804
Country/Territory:Germany
Phone:49-89-30622317
Fax:49-89-30622610
Email Address:turck@usa.net
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 25 October 2005]
Clinical Interests:
Anxiety disorders , Schizophrenia, Depression, Bipolar disorder , Borderline personality disorder
Research Focus:
Chemistry/pharmacology, Proteomics, Animal models, Protein structure/chemistry, Signal transduction
Work Sector(s):
Research institute
Web Sites:
Professional: http://www.mpipsykl.mpg.de/pages/english/research/turck_en.htm
What are the top three papers (not yours) you have read recently?
TURCK, C.W. Pharmacoproteomics. In, Handbook of Experimental Pharmacology, Vol. 169, Anxiety and Anxiolytic Drugs. Starke, K., ed., Springer Verlag Berlin Heidelberg, 547-560, 2005.
TURCK, C.W. Understanding and treating psychiatric and neurological disorders: the benefits of cerebrospinal fluid analysis. European Biopharmaceutical Review, 46-49, 2005.
Krömer, S.A., Keßler, M.S., Milfay, D., Birg, I.N., Bunck, M., Czibere, L., Panhuysen, M., Pütz, B., Deussing, J.M., Holsboer, F., Landgraf, R. and TURCK, C.W. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J. Neurosci., 25, 4375-4384, 2005.
Maccarrone, G., Birg, I., Malisch, E., Rosenhagen, M.C., Ditzen, C., Chakel, J.A., Mandel, F., Reimann, A., Doertbudak, C.-C., Haegler, K., Holsboer, F. and TURCK, C.W. In-depth analysis of the human CSF proteome using protein prefractionation. Clin. Proteomics, 1, 333-364, 2004.
If resources were not limited, what research projects would you pursue?
biomarkers discovery via proteomics



Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright